Q4299 Amniocore Pro+ HCPCS Reimbursement

HCPCS Level II code Q4299 denotes billing for Amniocore Pro+ measured per square centimeter as an add-on biologic graft product used in wound care and surgical applications. The code is important nationally because it standardizes reporting for an adjunctive amniotic membrane product that is increasingly used to support healing in complex wounds and surgical reconstructions. Accurate coding affects claims processing, product tracking, and aggregate utilization measurement across payers.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise synthesis of what the code represents, the clinical and service context for use, and the types of benchmarks and policy issues typically associated with add-on biologic products. The publication outlines how Q4299 is used in outpatient surgical and clinic settings, considerations for bundling with primary procedures, and common reporting practices relevant to commercial and government payers.

This resource summarizes expected analytic components such as utilization benchmarks, reimbursement policy updates, and clinical context for amniotic membrane applications. Data not available in the input.

Billing Code Overview

HCPCS Level II code Q4299 describes Amniocore Pro+, billed per square centimeter as an add-on product that is listed separately in addition to a primary procedure. The service type is amniotic membrane grafting/biologic wound matrix application, and the typical site of service is outpatient surgical or clinic settings where adjunctive graft materials are applied to wounds or surgical sites.

Data not available in the input.

Clinical Context

A 58-year-old patient with a chronic, non-healing lower extremity ulcer presents to a wound clinic for advanced biologic wound care. After evaluation including debridement and assessment of vascular status, the clinician elects to apply an amniotic membrane allograft product (Amniocore Pro+) to promote epithelialization and reduce inflammation. The product is supplied and billed per square centimeter as an add-on supply (Q4299) and is applied during the same encounter as the primary wound procedure (for example, excisional debridement or complex wound care). The clinical workflow includes wound measurement and photography, appropriate wound bed preparation (sharp or enzymatic debridement), hemostasis, application of the amniotic membrane graft sized to the measured wound area, securement with appropriate dressing, patient education on offloading and wound care, and scheduling of follow-up visits for graft assessment and additional applications if clinically indicated. Typical sites of service are outpatient wound care clinics, ambulatory surgical centers, and hospital outpatient departments where the primary wound procedure is performed.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier — standard reporting	Use when no special circumstance modifier applies to the service or supply billed with `Q4299`.

Taxonomy Code	Specialty	Notes
`2080S00000X`	General Surgery	Commonly performs debridement and wound procedures where amniotic allografts are applied.
`207L00000X`	Plastic Surgery	Frequently involved for complex soft tissue reconstruction and graft placement.
`208M00000X`	Vascular Surgery	Manages ischemic limb wounds and performs procedures that may include advanced biologic dressings.
`364S00000X`	Podiatry	Common provider for lower extremity and diabetic foot wounds using topical biologic products.
`261QM0800X`	Wound Care and Hyperbaric Medicine	Specialty dedicated to wound management and appropriate use of advanced graft products.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.421`	Non-pressure chronic ulcer of right ankle with necrosis of muscle	Chronic lower-extremity ulcer that may benefit from an amniotic membrane allograft to promote healing.
`L97.422`	Non-pressure chronic ulcer of left ankle with necrosis of muscle	Same clinical relevance for contralateral limb chronic ulcer management.
`L97.429`	Non-pressure chronic ulcer of unspecified ankle with necrosis of muscle	Applicable when laterality unspecified but clinical scenario requires advanced wound care.
`L97.511`	Non-pressure chronic ulcer of right heel and midfoot with necrosis of bone	Deep ulcerations with bone involvement where biologic dressings can be part of multimodal care after debridement.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers are a common indication for application of amniotic membrane products to support healing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue, first 20 sq cm or less	Often performed before application of the amniotic membrane to prepare the wound bed.
`11043`	Debridement, muscle and/or fascia, first 20 sq cm or less	Used when deeper debridement is required prior to graft application.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less	Alternative/additional code for application of advanced biologic grafts; used when coding primary graft placement procedures.
`97597`	Debridement (e.g., high-pressure water jet) of partial-thickness wounds, first 20 sq cm or less	Used in outpatient wound care settings as part of wound bed preparation ahead of allograft application.
`11044`	Debridement including bone, first 20 sq cm or less	Applies when osseous involvement requires more extensive debridement prior to amniotic product use.

OpenPayer

Summary & Overview

HCPCS Level II Q4299: Amniocore Pro+, Per Square Centimeter